New Delhi [India], January 21 (ANI): The Russian COVID-19 vaccine 'Sputnik V' will cost less than USD 10 (about Rs 730) per shot in India and the price is the same for all countries, Kirill Dmitriev, CEO of Russian Direct Investment Fund (RDIF) said on Thursday.
Abu Dhabi [UAE], January 21 (ANI/Sputnik): The United Arab Emirates (UAE) authorized emergency use of Russia's Sputnik V vaccine against the coronavirus, the Russian Direct Investment Fund (RDIF) confirmed on Thursday, noting that Phase III clinical trials were still ongoing in the UAE.
Moscow [Russia], January 21 (ANI/Sputnik): Russian Ambassador to Manila Marat Pavlov held talks with Philippine Secretary of Health Francisco Duque on the potential use of Russia's Sputnik V vaccine against COVID-19 in the Southeast Asian country, and told him that the Russian Direct Investm
Rio de Janeiro [Brazil], January 17 (ANI): The Brazil National Health Surveillance Agency (Anvisa) declined the request to approve the Russian-developed Sputnik V vaccine against COVID-19 for emergency use in Brazil.
Sokhumi [Abkhazia], January 15 (ANI/Sputnik): Five hundred doses of the two-dose Sputnik V COVID-19 vaccine have been delivered to a Russian military base in Abkhazia, the press service of the Russian Armed Forces' Southern Military District said on Friday.
Moscow [Russia], January 13 (ANI/Sputnik): The Russian Direct Investment Fund (RDIF) will deliver 10 million doses of Sputnik V coronavirus vaccine to Brazil in the first quarter of 2021, with a total of 150 million doses to be delivered this year, according to the vaccine's official Twitter
Caracas [Venezuela], January 13 (ANI/Sputnik): Venezuela will receive the first batch of 10 million doses of Russia's Sputnik V vaccine against COVID-19 in the upcoming weeks, President Nicolas Maduro said during his speech to the nation on Tuesday.
Hyderabad (Telangana) [India], January 12 (ANI): Dr Reddy's Laboratories has said that independent Data and Safety Monitoring Board (DSMB) reviewed the safety data from phase two clinical trial of Russia's Covid-19 vaccine Sputnik V and recommended phase three recruitment along with continui
Hyderabad (Telangana) [India], January 11 (ANI): The Russian made Covid-19 vaccine Sputnik V has met the primary endpoint of safety in the phase-2 clinical trials in India and has been recommended to continue the clinical trial without any modifications, according to an official statement.
Moscow [Russia], January 11 (ANI/Sputnik): Brazil will begin manufacturing the Russian-developed Sputnik V vaccine against the coronavirus disease on January 15, according to the vaccine's Twitter account.
Manila [Philippines], January 9 (ANI/Xinhua): The Department of Health (DOH) of the Philippines on Saturday reported 1,952 new COVID-19 cases, bringing the total in the country to 485,797.
Moscow [Russia], January 7 (ANI): The Russian Direct Investment Fund (RDIF) on Wednesday announced that Bolivia's State Agency for Medicines and Health Technologies has registered Sputnik V Covid-19 vaccine under emergency use authorisation procedure.